Treatment | A431 | MCF7/ADR | C26 | |||
---|---|---|---|---|---|---|
Groups | Mean | S.D. | Mean | S.D. | Mean | S.D. |
Control | 3.5 | 14.6 | 3.9 | 2.8 | 3.4 | 3.0 |
FD | 72.6 | 57.7 | 23.7 | 24.4 | 62.4 | 33.9 |
LD | 20.7 | 14.4 | 7.4 | 17.1 | 12.8 | 6.8 |
TAT-LD | 40.3 | 22.5 | 36.8 | 20.4 | 36.9 | 15.5 |
PEN-LD | 45.4 | 26.8 | 36.4 | 20.6 | 35.1 | 17.1 |
Values of fluorescence Intensity were obtained from histogram statistics of cell quest software. The data shown are representative of three similar experiments.
PEN-LD, PEN-conjugated liposomal doxorubicin.